[go: up one dir, main page]

IS6532A - Dosage formulation for oral administration of ziprofloxacin once daily - Google Patents

Dosage formulation for oral administration of ziprofloxacin once daily

Info

Publication number
IS6532A
IS6532A IS6532A IS6532A IS6532A IS 6532 A IS6532 A IS 6532A IS 6532 A IS6532 A IS 6532A IS 6532 A IS6532 A IS 6532A IS 6532 A IS6532 A IS 6532A
Authority
IS
Iceland
Prior art keywords
ziprofloxacin
oral administration
once daily
dosage formulation
dosage
Prior art date
Application number
IS6532A
Other languages
Icelandic (is)
Inventor
Talwar Naresh
N. Staniforth John
Rampal Ashok
Mukherji Gour
N. Vishwanathan Badri
Khera Brij
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of IS6532A publication Critical patent/IS6532A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS6532A 2000-03-03 2002-08-28 Dosage formulation for oral administration of ziprofloxacin once daily IS6532A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (1)

Publication Number Publication Date
IS6532A true IS6532A (en) 2002-08-28

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6532A IS6532A (en) 2000-03-03 2002-08-28 Dosage formulation for oral administration of ziprofloxacin once daily

Country Status (31)

Country Link
EP (1) EP1263409A1 (en)
JP (1) JP2003525229A (en)
KR (1) KR20030009374A (en)
CN (1) CN1420763A (en)
AP (2) AP2001002084A0 (en)
AR (1) AR032614A1 (en)
AU (1) AU3589701A (en)
BG (1) BG107055A (en)
BR (1) BR0108958A (en)
CA (1) CA2400950A1 (en)
CZ (1) CZ20022883A3 (en)
DO (1) DOP2001000130A (en)
EA (1) EA200200914A1 (en)
EC (1) ECSP013952A (en)
EE (1) EE200200497A (en)
GT (1) GT200100033A (en)
HN (1) HN2001000038A (en)
HR (1) HRP20020715A2 (en)
HU (1) HUP0204417A3 (en)
IL (1) IL151553A0 (en)
IS (1) IS6532A (en)
MX (1) MXPA02008568A (en)
NO (1) NO20024108L (en)
NZ (1) NZ520927A (en)
OA (1) OA12381A (en)
PE (1) PE20011113A1 (en)
PL (1) PL365071A1 (en)
SK (1) SK12542002A3 (en)
WO (1) WO2001064183A1 (en)
YU (1) YU66202A (en)
ZA (1) ZA200206764B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (en) 2003-11-04 2005-06-09 Bayer Healthcare Ag Flavor-containing drug formulations with improved pharmaceutical properties
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
ATE460934T1 (en) * 2006-07-19 2010-04-15 Tabuk Pharmaceutical Mfg Co PHARMACEUTICAL PREPARATIONS OF CIPROFLOXACIN
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
EP3419669A4 (en) * 2016-02-23 2019-10-30 Matripharm International Inc. DOUBLE-SPEED RELEASE COMPOSITION WITH HIGH MEDICAL DRUG CHARGE
WO2017165508A1 (en) 2016-03-24 2017-09-28 Im Therapeutics Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (en) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (en) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk Medice release solid pharmaceutical preparation of gastric suspending type sustained
DE4406424A1 (en) * 1994-02-28 1995-08-31 Bayer Ag Expandable dosage forms
DE19839057A1 (en) * 1998-08-28 2000-03-02 Koch Berthold Purge air controller for a drying device for compressed air
TR200100731T2 (en) * 1998-09-14 2001-06-21 Ranbaxy Laboratories Limited Orally controlled drug delivery system providing temporary and intermittent control

Also Published As

Publication number Publication date
NZ520927A (en) 2003-06-30
IL151553A0 (en) 2003-04-10
BR0108958A (en) 2003-09-30
AP2002002627A0 (en) 2002-09-30
OA12381A (en) 2004-09-06
GT200100033A (en) 2001-10-25
HUP0204417A2 (en) 2003-05-28
ECSP013952A (en) 2002-04-23
KR20030009374A (en) 2003-01-29
CZ20022883A3 (en) 2003-04-16
ZA200206764B (en) 2003-03-04
PL365071A1 (en) 2004-12-27
HUP0204417A3 (en) 2005-03-29
HRP20020715A2 (en) 2004-12-31
MXPA02008568A (en) 2003-02-24
EE200200497A (en) 2004-02-16
SK12542002A3 (en) 2003-05-02
PE20011113A1 (en) 2001-10-14
AP1485A (en) 2005-10-31
BG107055A (en) 2003-06-30
AU3589701A (en) 2001-09-12
CN1420763A (en) 2003-05-28
YU66202A (en) 2005-09-19
HN2001000038A (en) 2005-03-23
NO20024108D0 (en) 2002-08-28
EP1263409A1 (en) 2002-12-11
JP2003525229A (en) 2003-08-26
EA200200914A1 (en) 2003-02-27
AR032614A1 (en) 2003-11-19
NO20024108L (en) 2002-10-25
DOP2001000130A (en) 2004-03-31
WO2001064183A1 (en) 2001-09-07
CA2400950A1 (en) 2001-09-07
AP2001002084A0 (en) 2001-03-31

Similar Documents

Publication Publication Date Title
IS6892A (en) Pharmaceutical formulations, dosage forms and methods of administering oral epothilone
PL356358A1 (en) Solid dosage form of someticone for oral administration
EG23943A (en) Flash-melt oral dosage formulation
NO20020208L (en) Liquid compositions for oral administration
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
DK1158992T3 (en) Use of xenon for the preparation of a pharmaceutical composition for the treatment of neurointoxins
NO20020976D0 (en) Retarded, oral, pharmaceutical forms of administration
IS6994A (en) Aripiprazole solution for oral administration
IS4360A (en) Dosage oral dosage formulation
EE200000395A (en) Oral pharmaceutical pulsatile dosage form
NO20034862L (en) Oxycodone formulation for once daily administration
IL166489A (en) Two-layerd oral dosage form for once-a-day administration of paliperidone and uses thereof
NO20022058L (en) Pharmaceutical compositions
EE200000383A (en) Oral pharmaceutical extended release dosage form
NO20014738D0 (en) Tolperisone-containing pharmaceutical preparation for oral administration
DK1334717T3 (en) Pharmaceutical compositions for oral and topical administration
IS6532A (en) Dosage formulation for oral administration of ziprofloxacin once daily
HUP0500638A3 (en) Flashmelt oral dosage formulation
FI20000780L (en) Oral dosage form for controlled release of the drug
NO20040047L (en) Pharmaceutical formulation for intramuscular administration of fulvestrant
NO20025394D0 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
NO20021898L (en) Pharmaceutical composition containing ciclesonide for application to mucosa
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
NO20003799D0 (en) Incorporation of cholesterol-lowering agents into confectionary dosage forms
NO20032581D0 (en) Pharmaceutical formulation of gepirone for oral administration